Toward the development of a universal grading system for ovarian epithelial carcinoma: Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up

Cancer

Volumn 82, Issue 5, 1998, Pages 893-901

  Shimizu, Yoshio ^a   Kamoi, Seiryu ^b   Amada, Satoshi ^c   Akiyama, Futoshi ^a   Silverberg, Steven G ^b  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Clear cell carcinoma; Histopathologic grading; Invasive ovarian carcinoma; Mucinous; Serous

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; REPRODUCIBILITY;

CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0032030793     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W     Document Type: Article

References (28)

1. Pettersson F, Coppleson M, Creasman W, Ludwig H, Shepherd J. Annual report on the results of treatment in gynecologic cancer. Volume 20. Stockholm: International Federation of Gynecology and Obstetrics, 1988.
2. Malkasian GD Jr., Melton LJ III, O'Brien PC, Greene MH. Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Obstet Gynecol 1984;149:274-84.
3. Silverberg SG. Prognostic significance of pathologic features of ovarian carcinoma. Curr Top Pathol 1989;78:85-109.
4. Friedlander ML, Dembo AJ. Prognostic factors in ovarian cancer. Semin Oncol 1991;18:205-12.
5. Omura GA, Brady MF, Homesley HD, Jordan E, Major FJ, Buchsbaum HJ, et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group Experience. J Clin Oncol 1991;9:1138-50.
6. Ozols RF, Garvin AJ, Costa J, Simon RM, Young RC. Advanced ovarian cancer. Correlation of histologic grade with response to therapy and survival. Cancer 1980;45:572-81.
7. Sorbe B, Frankendal B, Veress B. Importance of histologic grading in the prognosis of epithelial ovarian cancer. Obstet Gynecol 1982;59:576-82.
8. Swenerton KD, Hislop TG, Spinelli J, LeRiche JC, Yang N, Boyes DA. Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstet Gynecol 1985;65:264-70.
9. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75:263-73.
10. Eisner RF, Teng F, Oliveira M, Leuchter R, Karlan B, Lagasse LD, et al. The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery. Gynecol Oncol 1994;55:108-10.
11. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
12. Serov SF, Scully RE, Sobin LH, editors. Histological typing of ovarian tumours. (International histological classification of tumours. No. 9). Geneva: World Health Organization, 1973:17-54.
13. Benda JA, Zaino R. GOG pathology manual. Buffalo, NY: Gynecologic Oncology Group, 1994.
14. Bichel P, Jakobsen A. A new histologic grading index in ovarian carcinoma. Int J Gynecol Pathol 1989;8:147-55.
15. SAS Institute Inc. SAS/STAT user's guide. Version 6. Volumes 1 and 2. 4th edition. Cary, NC: SAS Institute Inc., 1990.
16. Snedecor GW, Cochran WG. Statistical methods. 7th edition. Ames IA: Iowa State University Press, 1980.
17. Wilcoxon F. Individual comparison by ranking methods. Biometrics Bull 1945;1:80-3.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
20. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
21. Hernandez E, Bhagavan BS, Parmley TH, Rosenshein NB. Interobserver variability in the interpretation of epithelial ovarian cancer. Gynecol Oncol 1984;17:117-23.
22. Baak JPA, Langley FA, Talerman A, Delemarre JFM. The prognostic variability of ovarian tumor grading by different pathologists. Gynecol Oncol 1987;27:166-72.
23. Stalsberg H, Abeler V, Blom GP, Bostad L, Skarland E, Westgaard G. Observer variation in histologic classification of malignant and borderline ovarian tumors. Hum Pathol 1988;19:1030-5.
24. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol. 1997;15:3408-15.
25. Mauch PM, Ehrmann RL, Girths CT, Marco A, Knapp RC, Levene MB. Radiation therapy in stage II ovarian carcinoma. The influence of histologic grade. Cancer 1980;45:1344-51.
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
27. Crozier MA, Copeland LJ, Silva EG, Gershenson DM, Stringer CA. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 1989;35:199-203.
28. Kennedy AW, Biscotti CV, Hart WR, Webster KD. Ovarian clear cell adenocarcinoma. Gynecol Oncol 1989;32:342-9.